Advanced Biopolymers
Biopolymers, the most promising of which is Polylactide (PLA), are a type of plastic which, instead of being manufactured from petrochemicals, are made from sustainable feedstocks such as sugar, starch or Cellulose. Till date, the use of biopolymers, including first generation PLA, has been limited by their Physical properties and relatively high cost of manufacture. Next generation biopolymers, including Plastic component fabrication, Polysaccharides second generation PLA, are expected to be cheaper and to offer improved performance and a wider application reach, enabling them to capture an increasing share of the various markets for Biopolymers. Innovations has already achieved significant success with its early investments its £1.5m investment in obesity drug developer return up to £22m, following its sale for£100m in 2013, while the sale of Respivert, a small molecule drug discovery company, resulted in Innovations realizing £9.5m, a 4.7 return on investment. In the year to2015, Innovations invested £14.0m in 20 ventures, helping to launch three new companies.
- Chemistry of biopolymers
- 2 Plastic component fabrication using Biopolymers
- Polylactic acid in Biopolymers
- Nucleic acids in Biopolymers
- Polysaccharides in Biopolymers
- Polynucleotide in Biopolymers
- Micro fabrication techniques
- Production of Biopolymers from Acetobacter xylinum
Related Conference of Advanced Biopolymers
Advanced Biopolymers Conference Speakers
Recommended Sessions
- Advanced Biopolymers
- Biodegradable polymers
- Bioinformatics
- Bioplastics
- Biopolymer Applications
- Biopolymer Companies & Market
- Biopolymers as Materials
- Biopolymers for Tissue Engineering and Regenerative Medicine
- Biopolymers in Biofibers & Microbial Cellulose
- Biopolymers in Biomedical Applications
- Future & Scope of Biopolymers
- Green Composites in Biopolymers
- Natural Polymers
- Recycling & Waste management of Biopolymers